Bill > A07311

This bill requires health insurance policies in New York to provide coverage for human leukocyte antigen (HLA) testing, which is a specialized laboratory test used to determine tissue compatibility for bone marrow transplants. Specifically, the bill mandates that insurance policies covering hospital, surgical, or medical care must include coverage for HLA testing that identifies A, B, and DR antigens. The requirement applies to individual policies, group policies, and medical expense indemnity corporations. The bill includes an exception for policies covering employees in multiple states or those with benefit structures determined through multi-state collective bargaining. The new requirement will take effect on the first day of January following the bill's passage and will apply to all insurance policies issued, renewed, modified, or altered after that date. HLA testing is crucial in identifying genetically compatible donors for bone marrow transplants, which can be life-saving for patients with certain blood disorders or cancers, and this bill aims to ensure that patients have access to this important diagnostic test without additional financial burden.

Business and Industry

https://www.nysenate.gov/legislation/bills/2025/A7311